\-\ Texto\\:\\ \ \(0\)\
\-\ urinalysis\\ demonstrated\\ 4\\+\\ blood\\.\ \(0\)\
\-\ large\\ heterogeneous\\ enhancing\\ mass\\ arising\\ from\\ the\\ right\\ kidney\\.\ \(0\)\
\-\ renal\\ cell\\ carcinoma\ \(60\)\
\-\ this\\ large\\ enhancing\\ heterogeneous\\ mass\\ is\\ virtually\\ pathognomonic\\ for\\ renal\\ cell\\ carcinoma\\.\\ \\ renal\\ lymphoma\\ is\\ frequently\\ infiltrative\\ and\\ if\\ solid\\,\\ usually\\ hypoenhancing\\ when\\ compared\\ to\\ the\\ normal\\ renal\\ parenchyma\\.\\ \\ renal\\ metastases\\ are\\ usually\\ small\\ and\\ multifocal\\.\\ \\ oncocytomas\\ are\\ relatively\\ uncommon\\,\\ large\\,\\ homogeneous\\ masses\\ frequently\\ with\\ a\\ central\\ fibrous\\ scar\\ in\\ asymptomatic\\ patients\\.\ \(0\)\
\-\ 66\\ yo\\ female\\ with\\ painless\\ hematuria\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ renal\\:\\ 0\\.1528259255629803\ \(0\)\
\-\ hypoenhancing\\:\\ 0\\.08844314360531676\ \(0\)\
\-\ oncocytomas\\:\\ 0\\.08844314360531676\ \(0\)\
\-\ frequently\\:\\ 0\\.08817930084785607\ \(0\)\
\-\ 4\\+\\:\\ 0\\.0801913914557936\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.07481417039988109\ \(0\)\
\-\ large\\:\\ 0\\.06673365827968142\ \(0\)\
\-\ virtually\\:\\ 0\\.0644562028845755\ \(0\)\
\-\ enhancing\\:\\ 0\\.06380841744963713\ \(0\)\
\-\ urinalysis\\:\\ 0\\.0626210757437748\ \(0\)\
\-\ usually\\:\\ 0\\.06178400604444664\ \(0\)\
\-\ infiltrative\\:\\ 0\\.0583749454587899\ \(0\)\
\-\ carcinoma\\:\\ 0\\.057664944524187293\ \(0\)\
\-\ pathognomonic\\:\\ 0\\.05506980573738181\ \(0\)\
\-\ cell\\:\\ 0\\.054958112180511574\ \(0\)\
\-\ multifocal\\:\\ 0\\.05471441331893323\ \(0\)\
\-\ 66\\:\\ 0\\.05471441331893323\ \(0\)\
\-\ scar\\:\\ 0\\.053081066634248886\ \(0\)\
\-\ painless\\:\\ 0\\.05111583151092212\ \(0\)\
\-\ uncommon\\:\\ 0\\.049771302806391214\ \(0\)\
\-\ hematuria\\:\\ 0\\.04825410106153264\ \(0\)\
\-\ homogeneous\\:\\ 0\\.04815278332739087\ \(0\)\
\-\ relatively\\:\\ 0\\.04352932291371392\ \(0\)\
\-\ metastases\\:\\ 0\\.04346110059574981\ \(0\)\
\-\ parenchyma\\:\\ 0\\.04332581775467463\ \(0\)\
\-\ compared\\:\\ 0\\.04305977848453182\ \(0\)\
\-\ arising\\:\\ 0\\.042111949580190246\ \(0\)\
\-\ fibrous\\:\\ 0\\.041121741169727055\ \(0\)\
\-\ solid\\:\\ 0\\.040575555386980704\ \(0\)\
\-\ kidney\\:\\ 0\\.035837898274404874\ \(0\)\
\-\ masses\\:\\ 0\\.03438800473804866\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.03438800473804866\ \(0\)\
\-\ central\\:\\ 0\\.03347180186738046\ \(0\)\
\-\ yo\\:\\ 0\\.030611327658366213\ \(0\)\
\-\ demonstrated\\:\\ 0\\.029850237886392468\ \(0\)\
\-\ when\\:\\ 0\\.029134895685904827\ \(0\)\
\-\ lymphoma\\:\\ 0\\.029073793266541494\ \(0\)\
\-\ mass\\:\\ 0\\.02829669064160868\ \(0\)\
\-\ blood\\:\\ 0\\.027766798482253562\ \(0\)\
\-\ are\\:\\ 0\\.027735092203085752\ \(0\)\
\-\ if\\:\\ 0\\.027604088497388515\ \(0\)\
\-\ patients\\:\\ 0\\.026328269040071735\ \(0\)\
\-\ small\\:\\ 0\\.023435420052156174\ \(0\)\
\-\ female\\:\\ 0\\.020913812755331353\ \(0\)\
\-\ normal\\:\\ 0\\.015947767316655963\ \(0\)\
\-\ from\\:\\ 0\\.015076615632788242\ \(0\)\
\-\ is\\:\\ 0\\.0133878756758268\ \(0\)\
\-\ this\\:\\ 0\\.011442109682311108\ \(0\)\
\-\ right\\:\\ 0\\.010733710822743055\ \(0\)\
\-\ \\,\\:\\ 0\\.009668216625617405\ \(0\)\
\-\ for\\:\\ 0\\.008679858912413276\ \(0\)\
\-\ to\\:\\ 0\\.0050841441481307885\ \(0\)\
\-\ in\\:\\ 0\\.005016633692145891\ \(0\)\
\-\ a\\:\\ 0\\.004721426212126205\ \(0\)\
\-\ and\\:\\ 0\\.004285928707909963\ \(0\)\
\-\ the\\:\\ 0\\.003291649635800614\ \(0\)\
\-\ \\.\\:\\ 0\\.0029582946747788563\ \(0\)\
\-\ with\\:\\ 0\\.0027858137164259457\ \(0\)\
